⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19965861 | 1.00 | — | — | |
| SCHEMBL13452824 | 0.75 | — | — | |
| SCHEMBL2972549 | 0.75 | — | — | |
| SCHEMBL11146291 | 0.73 | — | — | |
| SCHEMBL23254162 | 0.71 | — | — | |
| SCHEMBL135174 | 0.71 | — | — | |
| SCHEMBL9430212 | 0.71 | — | — | |
| SCHEMBL23977698 | 0.71 | — | — | |
| SCHEMBL15830172 | 0.71 | — | — | |
| SCHEMBL5948230 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4129407-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS | Achillion Pharmaceuticals, Inc. (US) | 2023-02-08 | — | — | EP | disclosed |